Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release

• Status: Completed
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of the study is to determine the feasibility of providing buprenorphine maintenance to opioid-dependent offenders in a jail setting and of transitioning those patients to buprenorphine maintenance in the community after their release.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Development and Research Institutes, Inc.
• Collaborators: National Institute on Drug Abuse (NIDA); New York City Department of Health and Mental Hygiene; Western Michigan University
• Treatments: Buprenorphine; Methadone

Criteria

Inclusion Criteria:

• opioid dependent patients who meet eligibility requirements for the KEEP program,

• patients serving sentences who will remain confined for at least 10 days but less than 90 days in the EMTC facility (all male) at Rikers,

• willingness to accept buprenorphine treatment,

• expected to reside in New York City after release

• 18-65 years of age

Exclusion Criteria:

• receiving methadone treatment in the community at sentencing and remanded to Rikers

• took non-prescribed 'street methadone' within last 3 days

• currently receiving more than 20mg/day methadone

• current psychotic symptoms (e.g., schizophrenia, schizoaffective disorder) requiring referral for mental health intervention, or current treatment with antipsychotic medication)

• HIV infection with T lymphocytes less than 200 per mm of blood and/or presence of a serious opportunistic infection requiring treatment, or receiving the HIV medication atazanavir.

• unable to complete English language interview